Literature DB >> 20080899

(99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.

Wilmar de Graaf1, Krijn P van Lienden, Thomas M van Gulik, Roelof J Bennink.   

Abstract

UNLABELLED: Preoperative evaluation of future remnant liver (FRL) function is crucial in the determination of whether a patient can safely undergo liver resection. Although dynamic (99m)Tc-mebrofenin hepatobiliary scintigraphy (HBS) is used to measure FRL function, 2-dimensional planar images lack the ability to assess segmental liver function. Modern SPECT/CT cameras combine dynamic (99m)Tc-mebrofenin HBS with additional SPECT and the anatomic information of the CT scan. The aim of this study was to evaluate the additional value of (99m)Tc-mebrofenin SPECT for the measurement of segmental liver function and liver functional volume.
METHODS: Preoperative CT volumetry and (99m)Tc-mebrofenin HBS with SPECT were performed in 36 patients undergoing liver resection. In 18 patients, postoperative (99m)Tc-mebrofenin HBS with SPECT was performed within 3 d after operation. Dual-head dynamic acquisitions were used to calculate FRL function using anterior and geometric mean (Gmean) datasets. Total and FRL functional liver volumes were measured by SPECT.
RESULTS: Because of the anatomic position of the liver, the anterior projection resulted in an underestimation of FRL function in patients undergoing left hemihepatectomy. In patients with normal liver parenchyma, total functional liver volume was comparable to total liver volume measured by CT volumetry, indicating that (99m)Tc-mebrofenin SPECT is an accurate method to measure hepatic volume. In compromised livers, compared with normal livers, FRL function per cubic centimeter of liver volume was significantly less. In addition, liver function was not distributed homogeneously, with the segments to be resected relatively more affected. FRL function, measured by a combination of SPECT and dynamic HBS, was able to accurately predict actual postoperative remnant liver function.
CONCLUSION: The Gmean dataset is recommended for the assessment of hepatic function by dynamic planar (99m)Tc-mebrofenin HBS. The combination of SPECT data with the dynamic uptake function measured by planar HBS provides valuable visible and quantitative information regarding segmental liver function and is an accurate measure for FRL function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080899     DOI: 10.2967/jnumed.109.069724

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  48 in total

1.  Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using (99m)Tc-GSA SPECT/CT.

Authors:  Kasia P Cieslak; Roelof J Bennink; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

2.  A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization.

Authors:  Sandra van der Velden; Manon N G J A Braat; Tim A Labeur; Mike V Scholten; Otto M van Delden; Roelof J Bennink; Hugo W A M de Jong; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

3.  Is it time to standardize patient factors for HPB surgery?

Authors:  Saxon Connor
Journal:  HPB (Oxford)       Date:  2014-10       Impact factor: 3.647

4.  The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function.

Authors:  Henrik Nilsson; Silja Karlgren; Lennart Blomqvist; Eduard Jonas
Journal:  HPB (Oxford)       Date:  2014-10-09       Impact factor: 3.647

5.  Optimal use of hepatobiliary scintigraphy before liver resection.

Authors:  Pim B Olthof; Thomas M van Gulik; Roelof J Bennink
Journal:  HPB (Oxford)       Date:  2016-07-04       Impact factor: 3.647

6.  Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.

Authors:  Kasia P Cieslak; Roelof J Bennink; Wilmar de Graaf; Krijn P van Lienden; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-07-25       Impact factor: 3.647

7.  Hepatic metabolism of 11C-methionine and secretion of 11C-protein measured by PET in pigs.

Authors:  Jacob Horsager; Susanne Bach Lausten; Dirk Bender; Ole Lajord Munk; Susanne Keiding
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

8.  Staging laparoscopy in patients with hepatocellular carcinoma: is it useful?

Authors:  Lisette T Hoekstra; Matthanja Bieze; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

Review 9.  Management of liver cancer. The Surgeon's point of view.

Authors:  Pierre Rabinel; Damien Dousse; Fabrice Muscari; Bertrand Suc
Journal:  Rep Pract Oncol Radiother       Date:  2017-03-23

Review 10.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.